{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:18:34Z","timestamp":1768684714967,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12012-015-9316-0","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T03:46:35Z","timestamp":1425095195000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Phosphorylation State of GSK3\u03b2 Serine 9 Correlated to the Development of Valproic Acid-Associated Fetal Cardiac Teratogenicity, Fetal VPA Syndrome, Rescued by Folic Acid Administration"],"prefix":"10.1007","volume":"16","author":[{"given":"Wei-Hsuan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lwun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Tsang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shian-Ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Huei","family":"Liou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"key":"9316_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0272-0590(88)90112-1","volume":"11","author":"PE Binkerd","year":"1988","unstructured":"Binkerd, P. E., Rowland, J. M., Nau, H., & Hendrickx, A. G. (1988). Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague\u2013Dawley rats. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology, 11, 485\u2013493.","journal-title":"Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology"},{"key":"9316_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/tera.1420380405","volume":"38","author":"AG Hendrickx","year":"1988","unstructured":"Hendrickx, A. G., Nau, H., Binkerd, P., Rowland, J. M., Rowland, J. R., Cukierski, M. J., & Cukierski, M. A. (1988). Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: An interspecies comparison. Teratology, 38, 329\u2013345.","journal-title":"Teratology"},{"key":"9316_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/bdrb.20053","volume":"74","author":"E Menegola","year":"2005","unstructured":"Menegola, E., Di Renzo, F., Broccia, M. L., Prudenziati, M., Minucci, S., Massa, V., & Giavini, E. (2005). Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Birth Defects Research, Part B: Developmental and Reproductive Toxicology, 74, 392\u2013398.","journal-title":"Birth Defects Research, Part B: Developmental and Reproductive Toxicology"},{"key":"9316_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/tera.1420480206","volume":"48","author":"T Sonoda","year":"1993","unstructured":"Sonoda, T., Ohdo, S., Ohba, K., Okishima, T., & Hayakawa, K. (1993). Sodium valproate-induced cardiovascular abnormalities in the Jcl: ICR mouse fetus: Peak sensitivity of gestational day and dose-dependent effect. Teratology, 48, 127\u2013132.","journal-title":"Teratology"},{"key":"9316_CR5","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.61.6_suppl_2.S23","volume":"61","author":"MS Yerby","year":"2003","unstructured":"Yerby, M. S. (2003). Management issues for women with epilepsy: Neural tube defects and folic acid supplementation. Neurology, 61, S23\u2013S26.","journal-title":"Neurology"},{"key":"9316_CR6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1701-2163(16)32685-8","volume":"29","author":"RD Wilson","year":"2007","unstructured":"Wilson, R. D., Johnson, J. A., Wyatt, P., Allen, V., Gagnon, A., Langlois, S., et al. (2007). Pre-conceptional vitamin\/folic acid supplementation 2007: The use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. Journal of Obstetrics and Gynaecology Canada: JOGC\u00a0=\u00a0Journal d\u2019obstetrique et gynecologie du Canada: JOGC, 29, 1003\u20131026.","journal-title":"Journal of Obstetrics and Gynaecology Canada: JOGC\u00a0=\u00a0Journal d\u2019obstetrique et gynecologie du Canada: JOGC"},{"key":"9316_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","volume":"98","author":"C Kozma","year":"2001","unstructured":"Kozma, C. (2001). Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. American Journal of Medical Genetics, 98, 168\u2013175.","journal-title":"American Journal of Medical Genetics"},{"key":"9316_CR8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20050282","volume":"391","author":"M Bianchi","year":"2005","unstructured":"Bianchi, M., De Lucchini, S., Marin, O., Turner, D. L., Hanks, S. K., & Villa-Moruzzi, E. (2005). Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration. The Biochemical Journal, 391, 359\u2013370.","journal-title":"The Biochemical Journal"},{"key":"9316_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00246-002-9402-5","volume":"24","author":"JA Harris","year":"2003","unstructured":"Harris, J. A., Francannet, C., Pradat, P., & Robert, E. (2003). The epidemiology of cardiovascular defects, part 2: A study based on data from three large registries of congenital malformations. Pediatric Cardiology, 24, 222\u2013235.","journal-title":"Pediatric Cardiology"},{"key":"9316_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-199010000-00001","volume":"10","author":"RI Shader","year":"1990","unstructured":"Shader, R. I., & Greenblatt, D. J. (1990). Lithium and the newborn heart. Journal of Clinical Psychopharmacology, 10, 311.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"9316_CR11","first-page":"155","volume":"65","author":"S Zierler","year":"1985","unstructured":"Zierler, S. (1985). Maternal drugs and congenital heart disease. Obstetrics and Gynecology, 65, 155\u2013165.","journal-title":"Obstetrics and Gynecology"},{"key":"9316_CR12","doi-asserted-by":"crossref","first-page":"21383","DOI":"10.1074\/jbc.M401413200","volume":"279","author":"A Michael","year":"2004","unstructured":"Michael, A., Haq, S., Chen, X., Hsich, E., Cui, L., Walters, B., et al. (2004). Glycogen synthase kinase-3\u03b2 regulates growth, calcium homeostasis, and diastolic function in the heart. Journal of Biological Chemistry, 279, 21383\u201321393.","journal-title":"Journal of Biological Chemistry"},{"key":"9316_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-213X-7-93","volume":"7","author":"HC Lee","year":"2007","unstructured":"Lee, H. C., Tsai, J. N., Liao, P. Y., Tsai, W. Y., Lin, K. Y., Chuang, C. C., et al. (2007). Glycogen synthase kinase 3\u03b1 and 3\u03b2 have distinct functions during cardiogenesis of zebrafish embryo. BMC Developmental Biology, 7, 93.","journal-title":"BMC Developmental Biology"},{"key":"9316_CR14","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","volume":"118","author":"R Kerkela","year":"2008","unstructured":"Kerkela, R., Kockeritz, L., Macaulay, K., Zhou, J., Doble, B. W., Beahm, C., et al. (2008). Deletion of GSK-3\u03b2 in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. Journal Clinical Investigation, 118, 3609\u20133618.","journal-title":"Journal Clinical Investigation"},{"key":"9316_CR15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1242\/dev.124.11.2099","volume":"124","author":"MC Fishman","year":"1997","unstructured":"Fishman, M. C., & Chien, K. R. (1997). Fashioning the vertebrate heart: Earliest embryonic decisions. Development, 124, 2099\u20132117.","journal-title":"Development"},{"key":"9316_CR16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.RES.74.5.757","volume":"74","author":"MC Fishman","year":"1994","unstructured":"Fishman, M. C., & Stainier, D. Y. (1994). Cardiovascular development. Prospects for a genetic approach. Circulation Research, 74, 757\u2013763.","journal-title":"Circulation Research"},{"key":"9316_CR17","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1126\/science.1077857","volume":"298","author":"KD Poss","year":"2002","unstructured":"Poss, K. D., Wilson, L. G., & Keating, M. T. (2002). Heart regeneration in zebrafish. Science, 298, 2188\u20132190.","journal-title":"Science"},{"issue":"Suppl 1","key":"9316_CR18","doi-asserted-by":"crossref","first-page":"11889","DOI":"10.1073\/pnas.1834204100","volume":"100","author":"A Raya","year":"2003","unstructured":"Raya, A., Koth, C. M., Buscher, D., Kawakami, Y., Itoh, T., Raya, R. M., et al. (2003). Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proceedings of the National Academy of Sciences of the United States of America, 100(Suppl 1), 11889\u201311895.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9316_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng875","volume":"31","author":"AJ Sehnert","year":"2002","unstructured":"Sehnert, A. J., Huq, A., Weinstein, B. M., Walker, C., Fishman, M., & Stainier, D. Y. (2002). Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nature Genetics, 31, 106\u2013110.","journal-title":"Nature Genetics"},{"key":"9316_CR20","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1242\/dev.00844","volume":"130","author":"X Shu","year":"2003","unstructured":"Shu, X., Cheng, K., Patel, N., Chen, F., Joseph, E., Tsai, H. J., & Chen, J. N. (2003). Na, K-ATPase is essential for embryonic heart development in the zebrafish. Development, 130, 6165\u20136173.","journal-title":"Development"},{"key":"9316_CR21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/dvdy.10356","volume":"228","author":"CJ Huang","year":"2003","unstructured":"Huang, C. J., Tu, C. T., Hsiao, C. D., Hsieh, F. J., & Tsai, H. J. (2003). Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 228, 30\u201340.","journal-title":"Developmental Dynamics: An Official Publication of the American Association of Anatomists"},{"key":"9316_CR22","volume-title":"The zebrafish book: A guide for the laboratory use of zebrafish","author":"M Westerfield","year":"2007","unstructured":"Westerfield, M. (2007). The zebrafish book: A guide for the laboratory use of zebrafish. Eugene: University of Oregon Press."},{"key":"9316_CR23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., & Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 203, 253\u2013310.","journal-title":"Developmental Dynamics: An Official Publication of the American Association of Anatomists"},{"key":"9316_CR24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0301-5629(02)00564-1","volume":"28","author":"YL Ho","year":"2002","unstructured":"Ho, Y. L., Shau, Y. W., Tsai, H. J., Lin, L. C., Huang, P. J., & Hsieh, F. J. (2002). Assessment of zebrafish cardiac performance using Doppler echocardiography and power angiography. Ultrasound in Medicine and Biology, 28, 1137\u20131143.","journal-title":"Ultrasound in Medicine and Biology"},{"key":"9316_CR25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/dvdy.24173","volume":"243","author":"M Dozawa","year":"2014","unstructured":"Dozawa, M., Kono, H., Sato, Y., Ito, Y., Tanaka, H., & Ohshima, T. (2014). Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 243, 1401\u20131415.","journal-title":"Developmental Dynamics: An Official Publication of the American Association of Anatomists"},{"key":"9316_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejphar.2013.10.060","volume":"723","author":"S Boku","year":"2014","unstructured":"Boku, S., Nakagawa, S., Masuda, T., Nishikawa, H., Kato, A., Takamura, N., et al. (2014). Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3\u03b2 and \u03b2-catenin pathway. European Journal of Pharmacology, 723, 425\u2013430.","journal-title":"European Journal of Pharmacology"},{"key":"9316_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2013.02.013","volume":"106","author":"S Sintoni","year":"2013","unstructured":"Sintoni, S., Kurtys, E., Scandaglia, M., Contestabile, A., & Monti, B. (2013). Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3\u03b2 in rats. Pharmacology, Biochemistry and Behavior, 106, 8\u201315.","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"9316_CR28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","volume":"72","author":"G Chen","year":"1999","unstructured":"Chen, G., Huang, L. D., Jiang, Y. M., & Manji, H. K. (1999). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry, 72, 1327\u20131330.","journal-title":"Journal of Neurochemistry"},{"key":"9316_CR29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0890-6238(02)00059-X","volume":"16","author":"LC Fuller","year":"2002","unstructured":"Fuller, L. C., Cornelius, S. K., Murphy, C. W., & Wiens, D. J. (2002). Neural crest cell motility in valproic acid. Reproductive Toxicology, 16, 825\u2013839.","journal-title":"Reproductive Toxicology"},{"key":"9316_CR30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","volume":"90","author":"SE Hardt","year":"2002","unstructured":"Hardt, S. E., & Sadoshima, J. (2002). Glycogen synthase kinase-3\u03b2: A novel regulator of cardiac hypertrophy and development. Circulation Research, 90, 1055\u20131063.","journal-title":"Circulation Research"},{"key":"9316_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2010.06.042","volume":"644","author":"F Hua","year":"2010","unstructured":"Hua, F., Zhou, J., Liu, J., Zhu, C., Cui, B., Lin, H., et al. (2010). Glycogen synthase kinase-3\u03b2 negatively regulates TGF-\u03b21 and Angiotensin II-mediated cellular activity through interaction with Smad3. European Journal of Pharmacology, 644, 17\u201323.","journal-title":"European Journal of Pharmacology"},{"key":"9316_CR32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2005.07.008","volume":"211","author":"JE Dawson","year":"2006","unstructured":"Dawson, J. E., Raymond, A. M., & Winn, L. M. (2006). Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Toxicology and Applied Pharmacology, 211, 124\u2013132.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9316_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187153006776056657","volume":"6","author":"A Verrotti","year":"2006","unstructured":"Verrotti, A., Tana, M., Pelliccia, P., Chiarelli, F., & Latini, G. (2006). Recent advances on neural tube defects with special reference to valproic acid. Endocrine, Metabolic & Immune Disorders: Drug Targets, 6, 25\u201331.","journal-title":"Endocrine, Metabolic & Immune Disorders: Drug Targets"},{"key":"9316_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/bdra.20347","volume":"79","author":"H Zhu","year":"2007","unstructured":"Zhu, H., Wlodarczyk, B. J., Scott, M., Yu, W., Merriweather, M., Gelineau-van Waes, J., et al. (2007). Cardiovascular abnormalities in Folr1 knockout mice and folate rescue. Birth Defects Research, Part A: Clinical and Molecular Teratology, 79, 257\u2013268.","journal-title":"Birth Defects Research, Part A: Clinical and Molecular Teratology"},{"key":"9316_CR35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","volume":"73","author":"CL Harden","year":"2009","unstructured":"Harden, C. L., Pennell, P. B., Koppel, B. S., Hovinga, C. A., Gidal, B., Meador, K. J., et al. (2009). Practice parameter update: Management issues for women with epilepsy\u2014Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology, 73, 142\u2013149.","journal-title":"Neurology"},{"key":"9316_CR36","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1242\/dev.099325","volume":"140","author":"JW Buikema","year":"2013","unstructured":"Buikema, J. W., Mady, A. S., Mittal, N. V., Atmanli, A., Caron, L., Doevendans, P. A., et al. (2013). Wnt\/\u03b2-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes. Development, 140, 4165\u20134176.","journal-title":"Development"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-015-9316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-015-9316-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-015-9316-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T02:00:32Z","timestamp":1651370432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-015-9316-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1007\/s12012-015-9316-0","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,1]]}}}